| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |